NSETrading Window25 Jun 2026 · 25 Jun 2026, 11:38 am

Trading Window

Par Drugs and Chemicals Limited · PAR

✦ AI SummaryRegulatory

Par Drugs and Chemicals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk8/10
Balance Sheet Risk2/10
Liquidity Impact5/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Par Drugs And Chemicals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

Attachments (1)

📄

PAR_25062026113749_SignedTW30062026.pdf

pdf

Download →
View document text
("Par Registered Office : 815, Nilamber Triumph, Gotri-Vasna Road, Vadodara -390 007. Gujarat (INDIA). Ph.: +91-265-2991021 / 2991022 DRUGS AND CHEMICALS LIMITED Email: admin@)pardru9s.com CIN No.: L24117GJ1999PLC035512 __ www pardrugs.com PAR/CS/NSE/2026-27 /07 Date: 25/06/2026 The Manager Listing department, National Stock Exchange of India Limited Exchange Plaza, C-1, Block-G, Bandra Kurla Complex, Bandra (E), Mumbai-400 051, Maharashtra Subject: Intimation of Closure of Trading Window Ref.: NSE's Circular No. NSE/CML/2019/11 dated April 2, 2019, Clause 4 of the Schedule Band other applicable regulations of SEBI (Prohibition of Insider Trading) Regulations, 2015 Symbol - PAR, ISIN: INE04LG01015 Dear Sir/Madam, Pursuant to Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 and amendment made time to time till date and according to Company's Code of Conduct to Regulate Monitor And Report Trading by Insiders, we would like to inform you that the trading window for trading in securities of the Company will remain closed with effect from Wednesday, July 1, 2026 till the expiry of 48 hours after declaration of Unaudited standalone financial results of the Company for the quarter ended on 30th June, 2026 for Designated persons, Designated employees and their immediate relatives. The date of the Board Meeting to approve the Unaudited Standalone Financial Results for the quarter ended on 30th June, 2026 will be informed in due course. Accordingly, all the Insiders of the Company have been advised not to trade in the securities of the Company during the aforesaid period of Closure of Trading Window. Kindly take on the record and acknowledge the receipt. Yours Faithfully For PAR DRUGS AND CHEMICALS LIMITED (Sanket B. Trivedi) Company Secretary & Compliance Officer r